CDC20: Target/Biomarker Introduction, products summarized (antibody/ADC/bispecific/antigen/ORF vector/VLP) and disease/indication/condition/MOA for drug discovery and IVD

It's the GeneMedi's summary page for Target/Biomarker Introduction of CDC20. The page also collects GeneMedi's different modalities and formats products for CDC20 in therapeutics/drug discovery and IVD diagnostics, which is including antibody, ADC, bispecific, antigen, ORF vector, VLP, etc. With GeneMedi's target-insight database-GM ITD database, the CDC20 target is also connected to human indications/diseases/conditions/MOA.

Target sublocation: Introcelluar Protein.

CDC20 appears to act as a regulatory protein interacting with several other proteins at multiple points in the cell cycle.? It is required for two microtubule-dependent processes, nuclear movement prior to anaphase and chromosome separation. [provided by RefSeq, Jul 2008]

Target IDGM-T85241
Target NameCDC20
Gene ID991,107995,64515,100855774,101097259,515376,100053348
Gene Symbol and Synonyms2310042N09Rik,bA276H19.3,CDC20,CDC20A,OOMD14,OZEMA14,p55CDC
Uniprot AccessionQ12834,Q62623
Uniprot Entry NameCDC20_HUMAN,CDC20_RAT
Protein Sub-locationIntrocelluar Protein
CategoryTherapeutics Target
DiseaseBreast Cancer
Gene EnsemblENSG00000117399
Target ClassificationN/A


Pre-made anti-CDC20 inhibitory monoclonal antibody(mab, blocking antibody inhibitor)-benchmark antibody for drug discovery and mechanism of action (MOA) research

Pre-made anti-CDC20 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). The anti-CDC20 mab is expressed and produced by mammalian cell line as a benchmark reference therapeutic antibody for biological drug discovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Antibody NameSpeciesFormatClassified by tagDetail
Anti-CDC20 monoclonal antibodyHuman, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, EquinemabTherapeutics Target antibodyDetail



Recombinant multi-species CDC20/ CDC20A/ bA276H19.3 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CDC20 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.

Products NameSpeciesExpression PlatformDetail
CDC20 proteinHuman, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, EquineMammalian cellDetail



Pre-made CDC20 viral vector in GM Promise-ORFTM

Cat No.Products nameNM IDSpeciesTypeDetail
vGMLP002664human CDC20 Lentivirus particleNM_001255HumanLentivirus particleDetail
pGMLP002664human CDC20 Lentivirus plasmidNM_001255HumanLentivirus plasmidDetail
pGMAAV000206house mouse Cdc20 AAV plasmidnm_023223.2House MouseAAV plasmidDetail
pGMLPm002113mouse Cdc20 Lentivirus plasmidNM_023223MouseLentivirus plasmidDetail
vGMAAV000206house mouse Cdc20 AAV particlenm_023223.2House MouseAAV particleDetail
vGMLPm002113mouse Cdc20 Lentivirus particleNM_023223MouseLentivirus particleDetail

About Promise-ORFTM:
Discover the largest collection of ORF/cDNA expression clones from different species, including human, mouse, rat, and more with GeneMedi's Promise-ORFTM. Our collection of ORFs expression clones come in verified mammalian or viral vectors lentivirus, AAV, and adenovirus) and our Promise-ORFTM viral-ready expression vectors make it easy for you to improve viral vector packaging efficiency or directly transfect mammalian cells, resulting in stronger and easier expression detection. Click to search your GOI

If you want to obtain higher quantities of plasmids (mg), please visit GM TransExcellent Plasmid DNA Rapid Preparation Service.






GENEMEDI
Email: [email protected]   [email protected]
Telephone: +86-21-50478399   Fax: 86-21-50478399
Privacy Policy
<